Acinetobacter baumannii is a nosocomial pathogen responsible for an increasing number of infections in VA, civilian and military hospitals. This proposal will address a novel mechanism that regulates virulence in A. baumannii. This mechanism involves a molecular switch that interconverts A. baumannii between virulent and avirulent states. Cells in the virulent state grow as opaque colonies when viewed by indirect oblique lighting. In contrast, the avirulent form produces translucent colonies that are rapidly killed in-vivo by host defenses. The central component of this regulation is a transcriptional regulator (ABUW_1645) that acts as a bistable switch to drive the differentiation from opaque to translucent states. In addition, a peptide-based quorum sensing system activates the expression of this regulator through a two-component system when cells approach high density. The completion of our work will result in a greater understanding of this novel regulatory pathway that controls virulence. This information along with the strains constructed in this proposal will pave the way for the development of high- throughput screens to identify small molecules that either drive cells from the opaque (virulent) to the translucent (avirulent) state, or block the ability of translucent cells to switch to opaque. Ultimately, these inhibitors may result in the development of novel therapies to disable virulence in this increasingly important bacterial pathogen.
Acinetobacter baummannii is a leading bacterial pathogen in both VA and civilian hospitals and was a frequent cause of deep soft tissue infections in military personnel injured in Iraq and Afghanistan. The frequency of A. baumannii infections is increasing and the problem of antibiotic resistance has reached a critical stage. In fact, pan- resistant strains that are untreatable by all available antibiotics have become a reality with A. baumannii. This has prompted the Infectious Diseases Society of America (IDSA) to place A. baumannii on their list of ESKAPE pathogens, a group of bacteria that represent a critical threat to our population. This study will address a novel pathway regulating virulence in this bacterium and could lead to a new generation of therapies to treat A. baumannii infections.
|Anderson, Sarah E; Sherman, Edgar X; Weiss, David S et al. (2018) Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075. mSphere 3:|
|Chin, Chui Yoke; Tipton, Kyle A; Farokhyfar, Marjan et al. (2018) A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii. Nat Microbiol 3:563-569|
|Tipton, Kyle A; Chin, Chui-Yoke; Farokhyfar, Marjan et al. (2018) Role of Capsule in Resistance to Disinfectants, Host Antimicrobials, and Desiccation in Acinetobacter baumannii. Antimicrob Agents Chemother 62:|
|Howery, Kristen E; Clemmer, Katy M; ?im?ek, Emrah et al. (2015) Regulation of the Min Cell Division Inhibition Complex by the Rcs Phosphorelay in Proteus mirabilis. J Bacteriol 197:2499-507|
|Szostek, Bree A; Rather, Philip N (2013) Regulation of the swarming inhibitor disA in Proteus mirabilis. J Bacteriol 195:3237-43|
|Kurihara, Shin; Sakai, Yumi; Suzuki, Hideyuki et al. (2013) Putrescine importer PlaP contributes to swarming motility and urothelial cell invasion in Proteus mirabilis. J Biol Chem 288:15668-76|
|Stevenson, Lindsay G; Szostek, Bree A; Clemmer, Katy M et al. (2013) Expression of the DisA amino acid decarboxylase from Proteus mirabilis inhibits motility and class 2 flagellar gene expression in Escherichia coli. Res Microbiol 164:31-7|
|Morgenstein, Randy M; Rather, Philip N (2012) Role of the Umo proteins and the Rcs phosphorelay in the swarming motility of the wild type and an O-antigen (waaL) mutant of Proteus mirabilis. J Bacteriol 194:669-76|